| 产品名称 | Torcetrapib - CP 529414 |
| 产品货号 | Axon 2047 CAS [262352-17-0] MF C26H25F9N2O4MW 600.47 Purity: 99% Optical purity: Optically pure Soluble in DMSO Description Cholesteryl ester transfer protein (CETP) inhibitor; a drug being developed to treat hypercholesterolemia (elevated cholesterol levels) and prevent cardiovascular disease References Certificates Categories Extra info PJ Barter et al. Effects of torcetrapib in patients at high risk for coronary events. N. Engl. J. Med. 2007, 357(21), 2109-2122. SE Nissen et al. Effect of Torcetrapib on the Progression of Coronary Atherosclerosis. N. Engl. J. Med. 2007, 356, 1304-1316. Certificate of Analysis Material Safety Data Sheet Cardiovascular Diabetes & Metabolism CETP Pfizer Licensed Products Inhibitor of cholesterylester transfer protein (CETP) Chemical name (2R,4S)-ethyl 4-((3,5-bis(trifluoromethyl)benzyl)(methoxycarbonyl)amino)-2-ethyl-6-(trifluoromethyl)-3,4-dihydroquinoline-1(2H)-carboxylate Source information Pfizer compound; Sold for research purposes under agreement from Pfizer Inc. Parent CAS No. [262352-17-0] Order Size Unit Price Stock 10 mg €95.00 In Stock |
| 产品价格 | 现货询价，电话：010-67529703 |
| 产品规格 | |
| 产品品牌 | axonmedchem |
| 产品概述 | |
| 产品详情 |
Torcetrapib - CP 529414Axon 2047 CAS [262352-17-0] MF C26H25F9N2O4
Description
Cholesteryl ester transfer protein (CETP) inhibitor; a drug being developed to treat hypercholesterolemia (elevated cholesterol levels) and prevent cardiovascular disease
Inhibitor of cholesterylester transfer protein (CETP)
Chemical name(2R,4S)-ethyl 4-((3,5-bis(trifluoromethyl)benzyl)(methoxycarbonyl)amino)-2-ethyl-6-(trifluoromethyl)-3,4-dihydroquinoline-1(2H)-carboxylate Source informationPfizer compound; Sold for research purposes under agreement from Pfizer Inc.Parent CAS No.[262352-17-0] |
| 产品资料 |
